{
  "nct_id": "NCT05935332",
  "title": "Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma",
  "conditions": [
    "Asthma"
  ],
  "interventions": [
    "RPT193",
    "Placebo"
  ],
  "phase": "PHASE2",
  "summary": "Randomized, multi-center, double-blind, placebo-controlled, parallel group, proof of-concept study with RPT193 in subjects with T2-high, moderate-to-severe asthma who are partially controlled on medium or high doses of inhaled corticosteroids (ICS) in combination with long-acting beta 2 agonist (LABA).",
  "source": "clinicaltrials.gov",
  "collected_at": "2026-01-07T20:03:09.338707"
}